Cell therapy: types, regulation, and clinical benefits
AEH El-Kadiry, M Rafei, R Shammaa - Frontiers in Medicine, 2021 - frontiersin.org
Cell therapy practices date back to the 19th century and continue to expand on
investigational and investment grounds. Cell therapy includes stem cell-and non–stem cell …
investigational and investment grounds. Cell therapy includes stem cell-and non–stem cell …
Filling the gap: neural stem cells as a promising therapy for spinal cord injury
Spinal cord injury (SCI) can lead to severe motor, sensory and social impairments having a
huge impact on patients' lives. The complex and time-dependent SCI pathophysiology has …
huge impact on patients' lives. The complex and time-dependent SCI pathophysiology has …
Stem cells as a resource for treatment of infertility-related diseases
J Wang, C Liu, M Fujino, G Tong… - Current molecular …, 2019 - ingentaconnect.com
Worldwide, infertility affects 8-12% of couples of reproductive age and has become a
common problem. There are many ways to treat infertility, including medication, intrauterine …
common problem. There are many ways to treat infertility, including medication, intrauterine …
Advances, challenges, and perspectives in translational stem cell therapy for amyotrophic lateral sclerosis
E Abati, N Bresolin, G Comi, S Corti - Molecular Neurobiology, 2019 - Springer
Finding an effective therapeutic approach is a primary goal for current and future research
for amyotrophic lateral sclerosis (ALS), a fatal neurological disease characterized by …
for amyotrophic lateral sclerosis (ALS), a fatal neurological disease characterized by …
Advances in RNA Viral Vector Technology to Reprogram Somatic Cells: The Paramyxovirus Wave
B Sharp, R Rallabandi, P Devaux - Molecular Diagnosis & Therapy, 2022 - Springer
Ethical issues are a significant barrier to the use of embryonic stem cells in patients due to
their origin: human embryos. To further the development of stem cells in a patient …
their origin: human embryos. To further the development of stem cells in a patient …
The occurrence and development of induced pluripotent stem cells
Y Chen, M Li, Y Wu - Frontiers in Genetics, 2024 - frontiersin.org
The ectopic expression of four transcription factors, Oct3/4, Sox2, Klf4, and c-Myc (OSKM),
known as “Yamanaka factors,” can reprogram or stimulate the production of induced …
known as “Yamanaka factors,” can reprogram or stimulate the production of induced …
[HTML][HTML] Gene delivery methods and genome editing of human pluripotent stem cells
P Czerwińska, S Mazurek, I Kołodziejczak… - Reports of Practical …, 2019 - Elsevier
Induced pluripotent stem cells derived from normal somatic cells could be utilized to study
tumorigenesis through overexpression of specific oncogenes, downregulation of tumor …
tumorigenesis through overexpression of specific oncogenes, downregulation of tumor …
Experimental and computational approaches to direct cell reprogramming: recent advancement and future challenges
The process of direct cell reprogramming, also named transdifferentiation, permits for the
conversion of one mature cell type directly into another, without returning to a …
conversion of one mature cell type directly into another, without returning to a …
Induced pluripotent stem cells as vasculature forming entities
A Palladino, I Mavaro, C Pizzoleo, E De Felice… - Journal of Clinical …, 2019 - mdpi.com
Tissue engineering (TE) pursues the ambitious goal to heal damaged tissues. One of the
most successful TE approaches relies on the use of scaffolds specifically designed and …
most successful TE approaches relies on the use of scaffolds specifically designed and …